Increased expression of SARS-CoV-2 (Covid-19) adhesion sites on type II pneumocytes, small airway epithelium, and alveolar macrophages in smokers and patients with COPD
S. Brake (Launceston (TAS), Australia), W. Lu (Launceston (TAS), Australia), J. Markos (Launceston (TAS), Australia), J. Larby (Launceston (TAS), Australia), C. Chia (Launceston (TAS), Australia), G. Haug (Launceston (TAS), Australia), H. Weber (Launceston (TAS), Australia), K. Mcalinden (Launceston (TAS), Australia), A. Hardikar (Launceston (TAS), Australia), G. Singhera (Launceston (TAS), Canada), T. Hackett (Launceston (TAS), Canada), M. Eapen (Launceston (TAS), Australia), S. Sohal (Launceston (TAS), Australia)
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Session: Mechanistic pathways in chronic and new lung diseases
Session type: Oral Presentation
Number: 1217
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Brake (Launceston (TAS), Australia), W. Lu (Launceston (TAS), Australia), J. Markos (Launceston (TAS), Australia), J. Larby (Launceston (TAS), Australia), C. Chia (Launceston (TAS), Australia), G. Haug (Launceston (TAS), Australia), H. Weber (Launceston (TAS), Australia), K. Mcalinden (Launceston (TAS), Australia), A. Hardikar (Launceston (TAS), Australia), G. Singhera (Launceston (TAS), Canada), T. Hackett (Launceston (TAS), Canada), M. Eapen (Launceston (TAS), Australia), S. Sohal (Launceston (TAS), Australia). Increased expression of SARS-CoV-2 (Covid-19) adhesion sites on type II pneumocytes, small airway epithelium, and alveolar macrophages in smokers and patients with COPD. 1217
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects Source: Eur Respir J, 56 (2) 2002378; 10.1183/13993003.02378-2020 Year: 2020
Hyperoxia reversibly inhibits the transdifferentiation of alveolar type II (ATII) cells to alveolar type I (ATI) cells Source: Annual Congress 2005 - Cellular and molecular approaches to lung injury research Year: 2005
Decreased expression of TGFβ1 type II receptor in bronchial glands of smokers with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 98s Year: 2004
Chlamydia pneumoniae persists in TLR2 positive alveolar epithelial cells type II and alveolar macrophages of COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 350s Year: 2003
Modulation of NOS2 expression in co-cultures of human alveolar epithelial cells type II and alveolar macrophages Source: Eur Respir J 2001; 18: Suppl. 33, 161s Year: 2001
Expression of surface receptors on alveolar macrophages and monocytes from patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 453s Year: 2004
Type I and III collagen protein precursors in the airways of smokers and COPD-patients Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008
Increased galectin-3 expression and intra-epithelial neutrophils in small airways in severe COPD Source: Eur Respir J 2007; 29: 914-922 Year: 2007
Reduced haemeoxygenase-1 immunoreactivity in alveolar macrophages in severe COPD Source: Eur Respir J 2001; 18: Suppl. 33, 75s Year: 2001
PP207 – Targeting p16INK4a in alveolar type 2 cells to induce endogenous lung alveolar regeneration Source: ERS Lung Science Conference 2021 Year: 2021
RAGE, a marker of alveolar epithelial type I cell injury, predicts impaired alveolar fluid clearance in isolated perfused human lungs Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007
Increased expression of nuclear factor-κB in bronchial biopsies from smokers and patients with COPD Source: Eur Respir J 2002; 20: 556-563 Year: 2002
Antigen presenting cells of lower airways in interstitial lung diseases (ILD). Do alveolar lymphocytes possess the ability to present antigens? Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010
Expression of versican in large and small airways and parenchyma in lungs of non-smokers, smokers and COPD patients Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury Year: 2009
Effect of cigarette smoking on alveolar macrophages (AM) and lymphocytes (AL) apoptosis in selected interstitial lung diseases (ILD) Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008
Altered phenotype of COPD primary fibroblasts from airway and alveolar tissues: proliferation and apoptosis. Source: International Congress 2019 – Research and innovation in airway diseases Year: 2019
The relative expression of genes for arginine transporters in alveolar macrophages from BAL of non specific interstitial pneumonia patients (NSIP) Source: Annual Congress 2007 - Invasive and noninvasive methods to assess airway inflammation Year: 2007
ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19 Source: Eur Respir J, 55 (5) 2000688; 10.1183/13993003.00688-2020 Year: 2020
Decreased VEGF concentration in lung tissue and vascular injury during ARDS Source: Eur Respir J 2005; 25: 139-146 Year: 2005
The use of alveolar epithelial type I cell-selective markers to investigate lung injury and repair Source: Eur Respir J 2004; 24 : 664-673 Year: 2004